Home › Funds › PFM Health Sciences, LP › BTSG
PFM Health Sciences, LP position in BTSG
BRIGHTSPRING HEALTH SVCS INCORPORATED · Health Care
PFM Health Sciences, LP reported holding 141,914 shares of BTSG (BRIGHTSPRING HEALTH SVCS INCORPORATED) in its Q2 2026 13F filing — a position valued at US$9.9M, representing 0.87% of its reported portfolio and ranking #44 among its reported holdings. PFM Health Sciences, LP has disclosed BTSG holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How PFM Health Sciences, LP's BTSG position evolved
PFM Health Sciences, LP first disclosed a stake in BTSG in Q4 2025 at 118,525 shares (US$4.4M). The position peaked in Q2 2026 at 141,914 shares, worth US$9.9M. Across 3 filings, PFM Health Sciences, LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 141,914 shares valued at US$9.9M — a reduction of -45,421 shares quarter over quarter.. Notable position changes include a 58% increase in Q1 2026 (shares rose 64% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 118.53K | $4.44M | New |
| Q1 2026 | 187.34K | $7.98M | Add |
| Q2 2026 | 141.91K | $9.90M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BTSG and 13F data
BTSG (BRIGHTSPRING HEALTH SVCS INCORPORATED) is a Health Care company. 81 other funds we track also report a position in BTSG — the largest reported positions include Kohlberg Kravis Roberts & Co. L.P. (US$1.87B), FULLER & THALER ASSET MANAGEMENT, INC. (US$234.4M), Marshall Wace (US$183.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BTSG
- Kohlberg Kravis Roberts & Co. L.P. 26.83M sh · $1.87B · Q2 2026
- FULLER & THALER ASSET MANAGEMENT, INC. 3.36M sh · $234.39M · Q2 2026
- Marshall Wace 2.64M sh · $183.85M · Q2 2026
- Farallon Capital Management 1.73M sh · $120.85M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 1.73M sh · $120.85M · Q2 2026
- OBERWEIS ASSET MANAGEMENT INC/ 1.19M sh · $82.66M · Q2 2026
- SEVEN GRAND MANAGERS, LLC 1.00M sh · $69.74M · Q2 2026
- ALTA FOX CAPITAL MANAGEMENT, LLC 977.00K sh · $68.14M · Q2 2026
- LMR Partners LLP 676.23K sh · $47.16M · Q2 2026
- BRAIDWELL LP 596.75K sh · $41.62M · Q2 2026
- Integral Health Asset Management, LLC 550.00K sh · $38.36M · Q2 2026
- Sea Cliff Partners Management, LP 548.93K sh · $38.28M · Q2 2026
More on PFM Health Sciences, LP
FAQ
How long has PFM Health Sciences, LP held BTSG?
PFM Health Sciences, LP has disclosed BTSG holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is PFM Health Sciences, LP's current position in BTSG?
As of Q2 2026, PFM Health Sciences, LP holds 141.91K shares of BTSG (BRIGHTSPRING HEALTH SVCS INCORPORATED), valued at $9.90M, representing 0.87% of its reported portfolio and ranking #44.
Has PFM Health Sciences, LP been buying or selling BTSG?
In the latest 13F filing (Q2 2026), PFM Health Sciences, LP reduced its position in BTSG. The position peaked in Q2 2026 at 141.91K shares.
Which other funds hold BTSG?
Other major institutional holders of BTSG include Kohlberg Kravis Roberts & Co. L.P., FULLER & THALER ASSET MANAGEMENT, INC., Marshall Wace, among 81 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.